{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:15:45Z","timestamp":1778505345962,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["SALUD-2014-C01-233823"],"award-info":[{"award-number":["SALUD-2014-C01-233823"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","award":["FFIS\/IMSS\/PROT\/G16\/1589"],"award-info":[{"award-number":["FFIS\/IMSS\/PROT\/G16\/1589"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.arcmed.2024.103127","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T21:15:30Z","timestamp":1732569330000},"page":"103127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nutritional Status and Incidence of Hepatocellular Carcinoma in Patients with Compensated Liver Cirrhosis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-7209","authenticated-orcid":false,"given":"Marlene","family":"L\u00f3pez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleida","family":"Bautista-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Pilar","family":"Milke-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6592-5491","authenticated-orcid":false,"given":"Aldo","family":"Allende-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Moreno-Alc\u00e1ntar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-2392","authenticated-orcid":false,"given":"Segundo","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.103127_bib0001","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4254\/wjh.v6.i7.504","article-title":"Clinical outcomes of compensated and decompensated cirrhosis: a long term study","volume":"6","author":"Samonakis","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00423-012-1029-2","article-title":"Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up","volume":"398","author":"Desiderio","year":"2013","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.arcmed.2024.103127_bib0003","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2012.10.023","article-title":"The natural history of compensated HCV-related cirrhosis: a prospective long-term study","volume":"58","author":"Gomez","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0004","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/MEG.0b013e32834aa4bb","article-title":"Protein energy malnutrition predicts complications in liver cirrhosis","volume":"23","author":"Huisman","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0006","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","article-title":"Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis","volume":"12","author":"Bhanji","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.arcmed.2024.103127_bib0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle wasting is associated with mortality in patients with cirrhosis","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arcmed.2024.103127_bib0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1478-3231.2009.02135.x","article-title":"Nutritional status: its influence on the outcome of patients undergoing liver transplantation","volume":"30","author":"Merli","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2024.103127_bib0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-199402150-00030","article-title":"Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients","volume":"57","author":"Pikul","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2024.103127_bib0011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","article-title":"Sarcopenia and mortality after liver transplantation","volume":"211","author":"Englesbe","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.arcmed.2024.103127_bib0012","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/cancers15174223","article-title":"Lenvatinib or sorafenib treatment causing a decrease in skeletal muscle mass, an independent prognostic factor in hepatocellular carcinoma: a survival analysis using time-varying covariates","volume":"15","author":"Imai","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0013","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/cancers11081206","article-title":"Rapid depletions of subcutaneous fat mass and skeletal muscle mass predict worse survival in patients with hepatocellular carcinoma treated with sorafenib","volume":"11","author":"Imai","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0014","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/cancers12071795","article-title":"Rapid depletion of subcutaneous adipose tissue during sorafenib treatment predicts poor survival in patients with hepatocellular carcinoma","volume":"12","author":"Imai","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0015","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/CMAR.S167417","article-title":"Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy","volume":"10","author":"Kobayashi","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.arcmed.2024.103127_bib0016","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21358","article-title":"Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis","volume":"44","author":"Morgan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cld.2011.12.009","article-title":"Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses","volume":"16","author":"Periyalwar","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.arcmed.2024.103127_bib0018","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1572-0241.2002.07057.x","article-title":"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients","volume":"97","author":"Fattovich","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0019","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3346\/jkms.2015.30.11.1618","article-title":"Hepatocellular carcinoma risk of compensated cirrhosis patients with elevated HBV DNA levels according to serum aminotransferase levels","volume":"30","author":"Lee","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.arcmed.2024.103127_bib0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.27889","article-title":"Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load","volume":"62","author":"Sinn","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0021","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/liv.13649","article-title":"Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis","volume":"38","author":"Cacciola","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2024.103127_bib0022","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dky234","article-title":"Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV\/HCV-coinfected patients with cirrhosis","volume":"73","author":"Merchante","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arcmed.2024.103127_bib0023","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/apt.16116","article-title":"Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-na\u00efve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan","volume":"52","author":"Hu","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103127_bib0024","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000327571","article-title":"Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis","volume":"29","author":"Hayaishi","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.arcmed.2024.103127_bib0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.29578","article-title":"Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant","volume":"67","author":"Montano-Loza","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0026","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/jhep.2003.50093","article-title":"Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis","volume":"37","author":"Vel\u00e1zquez","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0027","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.1097\/MD.0000000000013438","article-title":"Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis","volume":"97","author":"Kim","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.arcmed.2024.103127_bib0029","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","article-title":"Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis","volume":"346","author":"Nishiguchi","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2024.103127_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(96)80022-5","article-title":"Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis","volume":"24","author":"Mazzella","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/jhep.2001.26820","article-title":"High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity","volume":"34","author":"Donato","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0032","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegn\u00f9","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2024.103127_bib0033","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cgh.2006.05.013","article-title":"Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis","volume":"4","author":"N'Kontchou","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0034","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jmv.20562","article-title":"Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections","volume":"78","author":"Kobayashi","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0035","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s10620-011-1621-2","article-title":"Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis","volume":"56","author":"Velosa","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2024.103127_bib0036","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0037","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2147\/CIA.S108589","article-title":"Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin","volume":"11","author":"Ng","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.arcmed.2024.103127_bib0038","article-title":"External validation of aMAP hepatocellular carcinoma risk score in patients with chronic hepatitis B-related cirrhosis receiving ETV or TDF therapy","volume":"8","author":"Gui","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2024.103127_bib0039","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.15679","article-title":"Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data","volume":"51","author":"Loomba","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103127_bib0040","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1007\/s10620-021-07099-8","article-title":"Visceral adipose tissue inflammation and radiographic visceral-to-subcutaneous adipose tissue ratio in patients with cirrhosis","volume":"67","author":"Ha","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2024.103127_bib0041","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4103\/ijmr.IJMR_1165_17","article-title":"Different gene expression profiles in subcutaneous & visceral adipose tissues from Mexican patients with obesity","volume":"149","author":"Ronquillo","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.arcmed.2024.103127_bib0042","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2018.04.015","article-title":"Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis","volume":"69","author":"Ebadi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0043","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hep.1840200121","article-title":"Skeletal muscle glycogen content in patients with cirrhosis","volume":"20","author":"Selberg","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103127_bib0044","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0676.2003.00805.x","article-title":"Reduced hepatic glycogen stores in patients with liver cirrhosis","volume":"23","author":"Kr\u00e4henb\u00fchl","year":"2003","journal-title":"Liver international"},{"key":"10.1016\/j.arcmed.2024.103127_bib0045","doi-asserted-by":"crossref","first-page":"14058","DOI":"10.18632\/oncotarget.24500","article-title":"Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment","volume":"9","author":"Imai","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2024.103127_bib0046","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2024.103127_bib0047","article-title":"Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis","volume":"4","author":"Nahon","year":"2021","journal-title":"JHEP Rep"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:42:15Z","timestamp":1778503335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440924001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0188440924001784"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103127","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional Status and Incidence of Hepatocellular Carcinoma in Patients with Compensated Liver Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103127"}}